Pharmacological treatment of chronic obstructive pulmonary disease

References

• AaronSDVandemheenKFergussonD2004The Canadian Optimal Therapy for COPD trial: design, organization and patient recruitmentCan Respir J11581515611808
   PubMedGoogle Scholar
• [ATS] American Thoracic Society1995Standards for the diagnosis and care of patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med152S771217582322
   PubMed Web of Science ®Google Scholar
• AnthonisenNRConnettJEKileyJP1994Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health StudyJAMA27214975057966841
   PubMed Web of Science ®Google Scholar
• AnthonisenNRManfredaJWarrenCP1987Antibiotic therapy in exacerbations of chronic obstructive pulmonary diseaseAnn Intern Med1061962043492164
   PubMed Web of Science ®Google Scholar
• BarberaJAReyesARocaJ1992Effect of intravenously administered aminophylline on ventilation/perfusion inequality during recovery from exacerbations of chronic obstructive pulmonary diseaseAm Rev Respir Dis1451328331595998
   PubMed Web of Science ®Google Scholar
• BarnesPJ1999Effect of β-agonists on inflammatory cellsJ Allergy Clin Immunol104S101710452784
   PubMed Web of Science ®Google Scholar
• BarnesPJ2000Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med161342410673166
   PubMed Web of Science ®Google Scholar
• BarnesPJ2003Theophylline: new perspectives for an old drugAm J Respir Crit Care Med1678131812623857
   PubMed Web of Science ®Google Scholar
• BarnesPJ2006Theophylline for COPDThorax61742416936233
   PubMed Web of Science ®Google Scholar
• BelliaVForesiABiancoS2002Efficacy and safety of oxitropium bromide, theophylline and their combination in COPD patients: a double-blind, randomised, multicentre studyRespir Med96881912418585
   PubMed Web of Science ®Google Scholar
• BelmanMJBotnickWCShinJW1996Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med153967758630581
   PubMed Web of Science ®Google Scholar
• BergerRSmithD1988Effect of inhaled metaproterenol on exercise performance in patients with stable “fixed” airway obstructionAm Rev Respir Dis13862493202416
   PubMed Web of Science ®Google Scholar
• BleeckerERBrittEJ1991Acute bronchodilating effects of ipratropium bromide and theophylline in chronic obstructive pulmonary diseaseAm J Med91247
   Web of Science ®Google Scholar
• BoydGMoriceAHPounsfordJC1997An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD)Eur Respir J10815219150318
   PubMed Web of Science ®Google Scholar
• BrochardLMancheboJWysockiM1995Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary diseaseN Engl J Med333817227651472
   PubMed Web of Science ®Google Scholar
• [BTS] The COPD Guidelines Group of the Standards of Care Committee of the BTS1997BTS guidelines for the management of chronic obstructive pulmonary diseaseThorax52Suppl 5S128
   Google Scholar
• BurgePSCalverleyPMJonesPW2000Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trialBMJ3201297130310807619
   PubMed Web of Science ®Google Scholar
• BurgePSCalverleyPMJonesPW2003Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE studyThorax58654812885977
   PubMed Web of Science ®Google Scholar
• CalverleyPM2000The future for tiotropiumChest1172 Suppl67S69S10673479
   PubMed Web of Science ®Google Scholar
• CalverleyPMBoonsawatWCsekeZ2003Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary diseaseEur Respir J229121914680078
   PubMed Web of Science ®Google Scholar
• CalverleyPPauwelsRVestboJ2003Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised control trialLancet3614495612583942
   PubMed Web of Science ®Google Scholar
• CasaburiRKukafkaDCooperCB2005Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPDChest1278091715764761
   PubMed Web of Science ®Google Scholar
• CasaburiRMahlerDAJonesPW2002A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary diseaseEur Respir J192172411866001
   PubMed Web of Science ®Google Scholar
• CazzolaMMateraMGSantangeloG1995Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response studyRespir Med89357627638371
   PubMed Web of Science ®Google Scholar
• CelliBR1996Current thoughts regarding treatment of chronic obstructive pulmonary diseaseMed Clin North Am805896098637305
   PubMed Web of Science ®Google Scholar
• CelliBRMcNeeW2004Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEur Respir J239324615219010
   PubMed Web of Science ®Google Scholar
• ChrystynHMulleyBAPeakeMD1988Dose response relation to oral theophylline in severe chronic obstructive airways diseaseBMJ2971506103147048
   PubMed Web of Science ®Google Scholar
• COMBIVENT Inhalation Aerosol Study Group1994In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter TrialChest1051411198181328
   PubMed Web of Science ®Google Scholar
• ComptonCHGubbJNiemanRInternational Study Group2001Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging studyLancet3582657011498212
   PubMed Web of Science ®Google Scholar
• ConfalonieriMMainardiEDella PortaR1998Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary diseaseThorax5358359797758
   PubMed Web of Science ®Google Scholar
• ConnorsAFJrDawsonNVThomasC1996Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)Am J Respir Crit Care Med154959678887592
   PubMed Web of Science ®Google Scholar
• CooperCBDavidsonACCameronIR1987Aminophylline, respiratory muscle strength and exercise tolerance in chronic obstructive airway diseaseBull Eur Physiopathol Respir2315223297214
   PubMedGoogle Scholar
• CottonMMBucknallCEDaggKD2000Early discharge for patients with exacerbations of chronic obstructive pulmonary disease: a randomized controlled trialThorax55902611050257
   PubMed Web of Science ®Google Scholar
• CuvelierAMuirJFBenhamouD2002Dry powder ipratropium bromide is as safe and effective as metered-dose inhaler formulation: a cumulative dose-response study in chronic obstructive pulmonary disease patientsRespir Care471596611812272
   PubMedGoogle Scholar
• DaviesLAngusRMCalverleyPM1999Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trialLancet3544566010465169
   PubMed Web of Science ®Google Scholar
• DaviesLWilkinsonMBonnerS2000“Hospital at home” versus hospital care in patients with exacerbations of chronic obstructive pulmonary disease: prospective randomised controlled trial”BMJ3211265811082090
   PubMed Web of Science ®Google Scholar
• DecramerMRutten-van MolkenMDekhuijzenPN2005Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trialLancet36515526015866309
   PubMed Web of Science ®Google Scholar
• DransfieldMTBaileyWC2004Fluticasone propionate/salmeterol for the treatment of chronic-obstructive pulmonary diseaseExpert Opin Pharmacother518152615264996
   PubMed Web of Science ®Google Scholar
• EdelsonJDComptonCNiemanR2001Cilomilast Ariflo a potent, selective phosphodiesterase-4 inhibitor for treatment of patient with chronic obstructive pulmonary disease: results of 6-month trialAm J Respir Crit Care Med163A771
   Google Scholar
• EmermanCLConnorsAFLukensTW1990Theophylline concentrations in patients with acute exacerbations of COPDAm J Emerg Med8289922363749
   PubMed Web of Science ®Google Scholar
• FanVSBrysonCLCurtisJR2003Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalisation: time-dependent analysisAm J Respir Crit Care Med16814889414525798
   PubMed Web of Science ®Google Scholar
• FeoktistovIPolosaRHolgateST1998Adenosine A2B receptors: a novel therapeutic target in asthma?Trends Pharmacol Sci19148539612090
   PubMed Web of Science ®Google Scholar
• FernandezAMunozJde la CalleB1994Comparison of one versus two bronchodilators in ventilated COPD patientsIntensive Care Med201992028014286
   PubMed Web of Science ®Google Scholar
• GambleEGrootendorstDCBrightlingCE2003Anti-inflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1689768212816740
   PubMed Web of Science ®Google Scholar
• [GICOPD] Global Initiative for Chronic Obstructive Lung Disease2001Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary diseaseNational Institutes of Health, National Heart, Lung, and Blood Institute Publication number 2701
   Google Scholar
• GrandjeanEMBerthetPRuffmannR2000Efficacy and oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trialsClin Ther222092110743980
   PubMed Web of Science ®Google Scholar
• GravilJHAl-RawasOACottonMM1998Home treatment of exacerbations of chronic obstructive pulmonary disease by an acute respiratory assessment serviceLancet351185359652670
   PubMed Web of Science ®Google Scholar
• GrossNJPettyTLFriedmanM1989Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center studyAm Rev Respir Dis1391188912523681
   PubMed Web of Science ®Google Scholar
• HakEvan EssenGABuskensE1998Is immunising all patients with chronic lung disease in the community against influenza cost effective? Evidence from a general practice based clinical prospective cohort study in Utrecht, The NetherlandsJ Epidemiol Community Health5212059578860
   PubMed Web of Science ®Google Scholar
• HatzelmannASchudtC2001Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitroJ Pharmacol Exp Ther2972677911259554
   PubMed Web of Science ®Google Scholar
• HayJGStonePCarterJ1992Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary diseaseEur Respir J5659641628722
   PubMed Web of Science ®Google Scholar
• HughesJMSealeJPTempleDM1983Effect of fenoterol on immunological release of leukotrienes and histamine from human lung in vitro: selective antagonism by beta-adrenoceptor antagonistsEur J Pharmacol95239456197312
   PubMed Web of Science ®Google Scholar
• IkedaANishimuraKKoyamaH1999Comparison of the bronchodilator effects of salbutamol delivered via a metered-dose inhaler with spacer, a dry-powder inhaler, and a jet nebulizer in patients with chronic obstructive pulmonary diseaseRespiration661192310202314
   PubMed Web of Science ®Google Scholar
• JohnsonMColemanRABusseWWHolgateST1995Mechanisms of action of adrenoceptor β2 agonistsAsthma and rhinitisCambridgeBalckwell Sci Pub127895
   Google Scholar
• JohnsonMRennardS2001Alternative mechanisms for long-acting β2-agonists in COPDChest1202587011451847
   PubMed Web of Science ®Google Scholar
• JonesPWWillitsLRBurgePS2003Disease severity and effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbationsEur Respir J21687312570111
   PubMed Web of Science ®Google Scholar
• JorenbyDELeischowSJNidesMA1999A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessationN Engl J Med3406859110053177
   PubMed Web of Science ®Google Scholar
• KeatingsVMJatakanonAWorsdellYMEffects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPDAm J Respir Crit Care Med15554289032192
   PubMed Web of Science ®Google Scholar
• KirstenDKWegnerREJorresRA1994Effects of theophylline withdrawal in severe chronic obstructive pulmonary diseaseChest104110178404175
   PubMed Web of Science ®Google Scholar
• KumeHHallIPWashabauRJ1994Beta-adrenergic agonists regulate KCa channels in airway smooth muscle by cAMP-dependent and -independent mechanismsJ Clin Invest9337197904270
   PubMed Web of Science ®Google Scholar
• LipworthBJ2005Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary diseaseLancet3651677515639300
   PubMed Web of Science ®Google Scholar
• [LHSRG] The Lung Health Study Research Group II2000Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary diseaseN Engl J Med3431902911136260
   PubMed Web of Science ®Google Scholar
• LloberesPRamisLMontserratJM1988Effect of three different bronchodilators during an exacerbation of chronic obstructive pulmonary diseaseEur Respir J153692971565
   PubMed Web of Science ®Google Scholar
• MacNeeW2002Acute exacerbations of COPD. Consensus conference on management of chronic obstructive pulmonary diseaseJ R Coll Physicians Edinb321626
   Google Scholar
• MacNeeWCalverleyPM2003Chronic obstructive pulmonary disease. 7: Management of COPDThorax58261512612309
   PubMed Web of Science ®Google Scholar
• MahlerDADonohueJFBarbeeRA1999Efficacy of salmeterol xinafoate in the treatment of COPDChest1159576510208192
   PubMed Web of Science ®Google Scholar
• MahlerDAWirePHorstmanD2002Effectiveness of fluticasone propionate and salmeterol combination delivered via the diskus device in the treatment of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med16610849112379552
   PubMed Web of Science ®Google Scholar
• MahonJLLaupacisAHodderRV1999Theophylline for irreversible chronic airflow limitation: a randomized study comparing n of 1 trials to standard practiceChest11538489925061
   PubMed Web of Science ®Google Scholar
• MaltaisFOstinelliJBourbeauJ2002Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trialAm J Respir Crit Care Med16569870311874817
   PubMed Web of Science ®Google Scholar
• ManningCDBurmanMChristensenSB1999Suppression of human inflammatory cell function by subtype-selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4BBr J Pharmacol1281393810602317
   PubMed Web of Science ®Google Scholar
• McKaySEHowieCAThomsonAH1993Value of theophylline treatment in patients handicapped by chronic obstructive lung diseaseThorax48227328497820
   PubMed Web of Science ®Google Scholar
• McNicholasWTCalverleyPMLeeA2004Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPDEur Respir J238253115218993
   PubMed Web of Science ®Google Scholar
• MoayyediPCongletonJPageRL1995Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary diseaseThorax5083477570433
   PubMed Web of Science ®Google Scholar
• MonsoERuizJRosellA1995Bacterial infection in chronicobstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brushAm J Respir Crit Care Med1521316207551388
   PubMed Web of Science ®Google Scholar
• MulloyEMcNicholasWT1993Theophylline improves gas exchange during rest, exercise, and sleep in severe chronic obstructive pulmonary diseaseAm Rev Respir Dis148103068214921
   PubMed Web of Science ®Google Scholar
• MurcianoDAubierMLecocguicY1984Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary diseaseN Engl J Med311349536738652
   PubMed Web of Science ®Google Scholar
• MurcianoDAuclairMHParienteR1989A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary diseaseN Engl J Med320152152498658
   PubMed Web of Science ®Google Scholar
• NanniniLCatedCJLassersonTJ2004Combined corticosteroid and long acting β-agonist in one inhaler for chronic obstructive pulmonary diseaseCochrane Database Syst Rev3CD00379415266502
   PubMedGoogle Scholar
• NicholKLMargolisKLWuorenmaJ1994The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the communityN Engl J Med331778848065407
   PubMed Web of Science ®Google Scholar
• NiewoehnerDEErblandMLDeupreeRH1999Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study GroupN Engl J Med3401941710379017
   PubMed Web of Science ®Google Scholar
• NishimuraKKoyamaHIkedaA1995The additive effect of theophylline on high-dose combination of inhaled salbutamol and ipratropium bromide in stable COPDChest107718237874943
   PubMed Web of Science ®Google Scholar
• [NPG] The Nebuliser Project Group of the British Thoracic Society Standards and Care Committee1997BTS Guidelines on current best practice for nebuliser treatmentThorax52Suppl 2S1106
   Google Scholar
• OjooJCMoonTMcGloneS2002Patients’ and carers’ preferences in two models of care for acute exacerbations of COPD: results of a randomised controlled trialThorax57167911828049
   PubMed Web of Science ®Google Scholar
• PaggiaroPLDahleRBakranI1998Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study GroupLancet351773809519948
   PubMed Web of Science ®Google Scholar
• PauwelsRALofdahlCGLaitinenLA1999Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary DiseaseN Engl J Med34019485310379018
   PubMed Web of Science ®Google Scholar
• PlantPKOwenJLElliottMW2000aOne year period prevalence study of respiratory acidosis in acute exacerbations of COPD: implications for the provision of non-invasive ventilation and oxygen administrationThorax55550410856313
   PubMed Web of Science ®Google Scholar
• PlantPKOwenJLElliottMW2000bEarly use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicenter randomised controlled trialLancet3551931510859037
   PubMed Web of Science ®Google Scholar
• PoolePJBlackPN2000Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary diseaseCochrane Database Syst Rev2CD00128710796634
   PubMedGoogle Scholar
• RabeKFBatemanEDO’DonnellD2005Roflumilast – an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomized controlled trialLancet3665637116099292
   PubMed Web of Science ®Google Scholar
• RahmanI2006Antioxidant therapies in COPDInt J COPD11531
   Google Scholar
• RennardSI2004Treatment of stable chronic obstructive pulmonary diseaseLancet36479180215337408
   PubMed Web of Science ®Google Scholar
• RennardSIAndersonWZuWallackR2001Use of a long-acting inhaled β2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med16310879211316640
   PubMed Web of Science ®Google Scholar
• RennardSISchachterNStrekM2006Cilomilast for COPD: results of a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4Chest129566616424413
   PubMed Web of Science ®Google Scholar
• Rodriguez-RoisinR2000Toward a consensus definition for COPD exacerbationsChest117Suppl 2398401S10669681
   PubMed Web of Science ®Google Scholar
• [RS] Respiratory system2003British National Formulary45th edLondonPharmaceutical Pr13165
   Google Scholar
• SachsFL1981Chronic bronchitisClin Chest Med279897030600
   PubMed Web of Science ®Google Scholar
• SealeJP1988Whither β-adrenoceptor agonists in the treatment of asthmaProg Clin Biol Res263367772454492
   PubMedGoogle Scholar
• SeemungalTADonaldsonGCPaulEA1998Effect of exacerbation on quality of life in patients with chronic obstructive pulmonay diseaseAm J Respir Crit Care Med1571418229603117
   PubMed Web of Science ®Google Scholar
• SeemungalTAHarper-OwenRBhowmikA2000Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary diseaseEur Respir J166778311106212
   PubMed Web of Science ®Google Scholar
• SenderovitzTVestboJFrandsenJ1999Steroid reversibility test followed by inhaled budesonide or placebo in outpatients with stable chronic obstructive pulmonary disease. The Danish Society of Respiratory MedicineRespir Med937151810581660
   PubMed Web of Science ®Google Scholar
• ShepperdSHarwoodDGrayA1998Randomised controlled trial comparing hospital at home care with inpatient hospital care. II: cost minimisation analysisBMJ316179169624069
   PubMed Web of Science ®Google Scholar
• ShepperdSHarwoodDJenkinsonC1998Randomised controlled trial comparing hospital at home care with inpatient hospital care. I: three month follow up of health outcomesBMJ3161786919624068
   PubMed Web of Science ®Google Scholar
• SiafakasNMVermeirePPrideNB1995Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task ForceEur Respir J813984207489808
   PubMed Web of Science ®Google Scholar
• SinDDTuJV2001Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med164580411520719
   PubMed Web of Science ®Google Scholar
• SinDDWuLAndersonJA2005Inhaled corticosteroids and mortality in chronic obstructive pulmonary diseaseThorax60992716227327
   PubMed Web of Science ®Google Scholar
• SkwarskaECohenGSkwarskiKM2000Randomized controlled trial of supported discharge in patients with exacerbations of chronic obstructive pulmonary diseaseThorax559071211050258
   PubMed Web of Science ®Google Scholar
• SoderlingSHBeavoJA2000Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functionsCurr Opin Cell Biol12174910712916
   PubMed Web of Science ®Google Scholar
• SolerNTorresAEwigS1998Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilationAm J Respir Crit Care Med15714985059603129
   PubMed Web of Science ®Google Scholar
• SorianoJBVestboJPrideNB2002Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practiceEur Respir J208192512412670
   PubMed Web of Science ®Google Scholar
• SuissaF2003Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studiesAm J Respir Crit Care Med168495312663327
   PubMed Web of Science ®Google Scholar
• SzafranskiWCukierARamirezA2003Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary diseaseEur Respir J21748112570112
   PubMed Web of Science ®Google Scholar
• TashkinDKannerRBaileyW2001Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trialLancet3571571511377644
   PubMed Web of Science ®Google Scholar
• ThompsonWHNielsonCPCarvalhoP1996Controlled trial of oral prednisone in outpatients with acute COPD exacerbationAm J Respir Crit Care Med154407128756814
   PubMed Web of Science ®Google Scholar
• TorphyTJUndemBJCieslinskiLB1993Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscleJ Pharmacol Exp Ther2651213238389856
   PubMed Web of Science ®Google Scholar
• UlrikCS1995Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover studyThorax5075047570409
   PubMed Web of Science ®Google Scholar
• UndemJBLichtensteinLMHardmanJGLimbirdLEGoodman GilmanA2001Drugs used in the treatment of asthmaThe pharmacological basis of therapeutics10th ednNew YorkMcGraw-Hill73354
   Google Scholar
• van NoordJAAumannJLJanssensE2006Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPDChest1295091716537846
   PubMed Web of Science ®Google Scholar
• van NoordJAde MunckDRBantjeTA2000Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropiumEur Respir J158788510853852
   PubMed Web of Science ®Google Scholar
• van SchayckCPDompelingEvan HerwaardenCL1991Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled studyBMJ3031426311837744
   PubMed Web of Science ®Google Scholar
• VathenenASBrittonJREbdenP1988High-dose inhaled albuterol in severe chronic airflow limitationAm Rev Respir Dis13885052462383
   PubMed Web of Science ®Google Scholar
• VestboJSorensenTLangeP1999Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trialLancet35318192310359405
   PubMed Web of Science ®Google Scholar
• VestboJTORCH Study Group2004The TORCH (towards a revolution in COPD health) survival study protocolEur Respir J242061015332386
   PubMed Web of Science ®Google Scholar
• WoutersEFPostmaDSFokkensB2005Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomized controlled trialThorax60480715923248
   PubMed Web of Science ®Google Scholar